Clinical Utility of SPECT/CT Imaging Post-Radioiodine Therapy: Does It Enhance Patient Management in Thyroid Cancer?

Publisher： Karger

E-ISSN： 2235-0802|4|4|239-245

ISSN： 2235-0640

Source： European Thyroid Journal, Vol.4, Iss.4, 2015-0, pp. : 239-245

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Radioiodine Ablation following Thyroidectomy for Differentiated Thyroid Cancer: Literature Review of Utility, Dose, and Toxicity


By  

European Thyroid Journal, Vol. 6, Iss. 4, 2017-03 ,pp. : 187-196

Karger

Access to resources Recommend Favorite

Can the American Thyroid Association Risk of Recurrence Predict Radioiodine Refractory Disease in Differentiated Thyroid Cancer?

By  

European Thyroid Journal, Vol. 5, Iss. 4, 2016-10 ,pp. : 261-267

Karger

Access to resources Recommend Favorite

Radioiodine Treatment and Thyroid Hormone Suppression Therapy for Differentiated Thyroid Carcinoma: Adverse Effects Support the Trend toward Less Aggressive Treatment for Low-Risk Patients

By  

European Thyroid Journal, Vol. 4, Iss. 2, 2015-06 ,pp. : 82-92

Karger

Access to resources Recommend Favorite

Prospective Study Confirms that Radioiodine Remnant Ablation Is Not Necessary in Low-Risk Differentiated Thyroid Cancer

By  

European Thyroid Journal, Vol. 5, Iss. 1, 2016-01 ,pp. : 7-8

Karger

Access to resources Recommend Favorite

Greater Efficacy of Total Thyroidectomy versus Radioiodine Therapy on Hyperthyroidism and Thyroid-Stimulating Immunoglobulin Levels in Patients with Graves’ Disease Previously Treated with Antithyroid Drugs

By  

European Thyroid Journal, Vol. 1, Iss. 2, 2012-06 ,pp. : 122-128

Karger

Access to resources Recommend Favorite